Symptoms
Gingivitis symptoms can include: swollen gums, redness of the gums, tenderness when the gums are touched, tenderness when chewing, pus around the teeth, or a bad taste in the mouth. A common gingivitis symptom is noticeable accumulations of tartar or plaque on the teeth. Another common gingivitis symptom is blood on the toothbrush while brushing teeth. When gingivitis symptoms are advanced, the disease often spreads to the bony tissues, which are located under the gums and support the teeth. In later stages of periodontal disease, the teeth can become loose and severely infected with pus that oozes out from around the sockets.
Gingivitis treatment is very effective if the disease is caught in time. The most effective gingivitis treatment or gum disease treatment is to prevent gingivitis and gum disease from getting started. Gingivitis treatment begins with regular daily brushing of the teeth to remove plague and tartar. Scraping of the tongue is also important to remove bacteria. Many people overlook these important parts of oral hygiene, but they are essential for gingivitis treatment.
Gingivitis treatment, including treatment for receding gums, bleeding gums, canker sores, and other problems of the teeth and gums, does not have to be an arduous task
Treatment
Non-antibiotic approach for treating the underlying infection responsible for periodontal disease. After routine scaling, the dentist will apply the compound directly into the periodontal pockets and around the gum line of affected teeth. The compound quickly penetrates the plaque preferentially binding to multiple structural components in bacteria, including their toxic secretions. Laser light is then applied directly to the affected sites using a fiber optic probe. A powerful free-radical reaction destroys the targeted bacteria and the associated toxins such as collagenase.
Periowave is a revolutionary new adjunctive treatment bringing the power and ease of photodynamic disinfection¹ to the treatment of periodontal diseases. The patented process was developed by Professor Michael Wilson and colleagues at the Eastman Dental Institute, London, England and is licensed to Ondine Biopharma Corporation by UCL Biomedica PLC, University College London.
